Teikyo University School of Medicine, Tokyo, Japan.
Teikyo University School of Medicine, Tokyo, Japan.
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2210-2216. doi: 10.1016/j.jcin.2016.08.035.
The aim of this study was to determine the impact of pre-existing right bundle branch block (RBBB) on clinical outcomes after transcatheter aortic valve replacement (TAVR).
The impact of pre-existing RBBB on clinical outcomes after TAVR is unknown.
Between October 2013 and August 2015, 749 patients undergoing TAVR using the Edwards SAPIEN XT prosthesis were prospectively enrolled in the OCEAN-TAVI (Optimized Transcatheter Valvular Intervention) registry from 8 Japanese centers. Electrocardiograms were obtained at baseline. After the procedure, follow-up outpatient visits or telephone interviews were conducted at 30 days, 6 months, and yearly.
A total of 102 patients (13.6%) had pre-existing RBBB. The incidence of new pacemaker implantation was significantly higher in the RBBB group (17.6% vs. 2.9%; p < 0.01). The Kaplan-Meier analysis revealed that cardiovascular survival probability was significantly lower in the RBBB group than the no-RBBB group (log-rank p < 0.01). Patients with RBBB and without pacemakers were at higher risk for cardiovascular mortality in the early phase after discharge, and patients with RBBB and pacemakers had higher cardiovascular mortality at mid-term follow-up (log-rank p = 0.01). A multivariate Cox regression model indicated that pre-existing RBBB (hazard ratio: 2.59; 95% confidence interval: 1.15 to 5.85; p < 0.01) was an independent predictor of cardiovascular mortality.
Patients with RBBB demonstrated an increased risk for cardiovascular mortality after TAVR, and patients with RBBB and without pacemakers were at higher risk for cardiac death early after discharge. Patients with prior RBBB should be carefully monitored after undergoing TAVR.
本研究旨在探讨预存右束支传导阻滞(RBBB)对经导管主动脉瓣置换术(TAVR)后临床结局的影响。
预存 RBBB 对 TAVR 后临床结局的影响尚不清楚。
2013 年 10 月至 2015 年 8 月,来自日本 8 家中心的 OCEAN-TAVI(优化经导管瓣膜干预)注册研究前瞻性纳入了 749 例行 Edwards SAPIEN XT 瓣膜置入的 TAVR 患者。所有患者在基线时均行心电图检查。术后 30 天、6 个月和 1 年进行门诊随访或电话随访。
共 102 例(13.6%)患者存在预存 RBBB。RBBB 组新发起搏器植入率显著高于无 RBBB 组(17.6%比 2.9%;p<0.01)。Kaplan-Meier 分析显示,RBBB 组心血管生存率显著低于无 RBBB 组(log-rank p<0.01)。在出院后早期,无起搏器的 RBBB 患者发生心血管死亡的风险更高,而有起搏器的 RBBB 患者在中期随访时发生心血管死亡的风险更高(log-rank p=0.01)。多变量 Cox 回归模型表明,预存 RBBB(风险比:2.59;95%置信区间:1.15 至 5.85;p<0.01)是心血管死亡的独立预测因素。
RBBB 患者 TAVR 后心血管死亡风险增加,无起搏器的 RBBB 患者出院后早期发生心脏性死亡的风险更高。行 TAVR 后应密切监测存在预存 RBBB 的患者。